Skip to main content
Premium Trial:

Request an Annual Quote

'Glaring' Opening at FDA

President Joe Biden has yet to nominate someone to lead the US Food and Drug Administration, an opening the New York Times calls "glaring" in light of the COVID-19 pandemic.

It adds that both Joshua Sharfstein, who was deputy commissioner at FDA during the Obama Administration, and Janet Woodcock, the current acting commissioner, are under consideration for the position and have both undergone some vetting for the position. Others — including David Kessler, a former FDA commissioner; Amy Abernethy, FDA's principal deputy commissioner; and Luciana Borio, a former acting chief scientist at FDA — have also been floated as candidates.

According to the Times, the selection is under particularly high scrutiny. In addition to the agency's involvement in reviewing new vaccines and treatments for SARS-CoV-2, it oversees other drugs, medical devices, and tobacco. It adds that the central point of contention between the candidates centers on how the next commissioner would juggle the agency's mission to both get drugs to market and the need to ensure they are safe and effective.

"I'm surprised it's become such a public discussion for this particular job," Wayne Pines, a public relations specialist who advised former FDA Commissioner Stephen Hahn, tells the Times. "That has never really happened before."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.